Cargando…

Dermal Delivery of Niacinamide—In Vivo Studies

In vivo human studies are considered to be the “gold standard” when investigating (trans)dermal delivery of actives. Previously, we reported the effects of a range of vehicles on the delivery of niacinamide (NIA) using conventional Franz cell studies. In the present work, dermal delivery of NIA was...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yanling, Kung, Chin-Ping, Iliopoulos, Fotis, Sil, Bruno C., Hadgraft, Jonathan, Lane, Majella E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156363/
https://www.ncbi.nlm.nih.gov/pubmed/34069268
http://dx.doi.org/10.3390/pharmaceutics13050726
_version_ 1783699427508092928
author Zhang, Yanling
Kung, Chin-Ping
Iliopoulos, Fotis
Sil, Bruno C.
Hadgraft, Jonathan
Lane, Majella E.
author_facet Zhang, Yanling
Kung, Chin-Ping
Iliopoulos, Fotis
Sil, Bruno C.
Hadgraft, Jonathan
Lane, Majella E.
author_sort Zhang, Yanling
collection PubMed
description In vivo human studies are considered to be the “gold standard” when investigating (trans)dermal delivery of actives. Previously, we reported the effects of a range of vehicles on the delivery of niacinamide (NIA) using conventional Franz cell studies. In the present work, dermal delivery of NIA was investigated in vivo in human subjects using confocal Raman spectroscopy (CRS) and tape stripping (TS). The vehicles investigated included propylene glycol (PG), Transcutol(®) P (TC), binary combinations of PG with oleic acid (OA) or linolenic acid (LA) and a ternary system comprising of TC, caprylic/capric triglyceride (CCT) and dimethyl isosorbide (DMI). For the CRS studies, higher area under curve (AUC) values for NIA were observed for the PG:LA binary system compared with PG, TC and TC:CCT:DMI (p < 0.05). A very good correlation was found between the in vitro cumulative permeation of NIA and the AUC values from Raman intensity depth profiles, with a Pearson correlation coefficient (R(2)) of 0.84. In addition, an excellent correlation (R(2) = 0.97) was evident for the signal of the solvent PG and the active. CRS was also shown to discriminate between NIA in solution versus crystalline NIA. The findings confirm that CRS is emerging as a powerful approach for dermatopharmacokinetic studies of both actives and excipients in human.
format Online
Article
Text
id pubmed-8156363
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81563632021-05-28 Dermal Delivery of Niacinamide—In Vivo Studies Zhang, Yanling Kung, Chin-Ping Iliopoulos, Fotis Sil, Bruno C. Hadgraft, Jonathan Lane, Majella E. Pharmaceutics Article In vivo human studies are considered to be the “gold standard” when investigating (trans)dermal delivery of actives. Previously, we reported the effects of a range of vehicles on the delivery of niacinamide (NIA) using conventional Franz cell studies. In the present work, dermal delivery of NIA was investigated in vivo in human subjects using confocal Raman spectroscopy (CRS) and tape stripping (TS). The vehicles investigated included propylene glycol (PG), Transcutol(®) P (TC), binary combinations of PG with oleic acid (OA) or linolenic acid (LA) and a ternary system comprising of TC, caprylic/capric triglyceride (CCT) and dimethyl isosorbide (DMI). For the CRS studies, higher area under curve (AUC) values for NIA were observed for the PG:LA binary system compared with PG, TC and TC:CCT:DMI (p < 0.05). A very good correlation was found between the in vitro cumulative permeation of NIA and the AUC values from Raman intensity depth profiles, with a Pearson correlation coefficient (R(2)) of 0.84. In addition, an excellent correlation (R(2) = 0.97) was evident for the signal of the solvent PG and the active. CRS was also shown to discriminate between NIA in solution versus crystalline NIA. The findings confirm that CRS is emerging as a powerful approach for dermatopharmacokinetic studies of both actives and excipients in human. MDPI 2021-05-14 /pmc/articles/PMC8156363/ /pubmed/34069268 http://dx.doi.org/10.3390/pharmaceutics13050726 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zhang, Yanling
Kung, Chin-Ping
Iliopoulos, Fotis
Sil, Bruno C.
Hadgraft, Jonathan
Lane, Majella E.
Dermal Delivery of Niacinamide—In Vivo Studies
title Dermal Delivery of Niacinamide—In Vivo Studies
title_full Dermal Delivery of Niacinamide—In Vivo Studies
title_fullStr Dermal Delivery of Niacinamide—In Vivo Studies
title_full_unstemmed Dermal Delivery of Niacinamide—In Vivo Studies
title_short Dermal Delivery of Niacinamide—In Vivo Studies
title_sort dermal delivery of niacinamide—in vivo studies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156363/
https://www.ncbi.nlm.nih.gov/pubmed/34069268
http://dx.doi.org/10.3390/pharmaceutics13050726
work_keys_str_mv AT zhangyanling dermaldeliveryofniacinamideinvivostudies
AT kungchinping dermaldeliveryofniacinamideinvivostudies
AT iliopoulosfotis dermaldeliveryofniacinamideinvivostudies
AT silbrunoc dermaldeliveryofniacinamideinvivostudies
AT hadgraftjonathan dermaldeliveryofniacinamideinvivostudies
AT lanemajellae dermaldeliveryofniacinamideinvivostudies